ACADIAN ASSET MANAGEMENT LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 52 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$52,000
+126.1%
2,025
+97.0%
0.00%
Q4 2020$23,000
-75.8%
1,028
-76.3%
0.00%
Q4 2019$95,000
-57.8%
4,334
-81.6%
0.00%
-100.0%
Q1 2018$225,000
+22400.0%
23,566
+7151.1%
0.00%
Q1 2017$1,000
-92.3%
325
-66.3%
0.00%
Q2 2015$13,0009640.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$103,638,00010.86%
Aquilo Capital Management, LLC 1,454,686$36,949,0007.45%
RTW INVESTMENTS, LP 7,152,918$181,684,0005.11%
EcoR1 Capital, LLC 2,721,993$69,139,0005.11%
BRIDGER MANAGEMENT, LLC 1,473,568$37,429,0003.47%
DAFNA Capital Management LLC 454,236$11,538,0003.33%
Parkman Healthcare Partners LLC 300,805$7,640,0002.15%
ACUTA CAPITAL PARTNERS, LLC 170,000$4,318,0001.25%
Integral Health Asset Management, LLC 110,000$2,794,0000.84%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,013,087$25,732,0000.63%
View complete list of DICERNA PHARMACEUTICALS INC shareholders